Latest Breaking News On - Julie dewey - Page 8 : comparemela.com

Nevro Names Kevin Thornal as New Chief Executive Officer and President

/PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of.

Redwood cityUnited statesMichael demaneKevin thornalD keith grossmanJulie deweyNevro corpCorp communicationsHologic incSouthern methodist universityGlobal diagnostic solutionsSkeletal healthSkeletal health for the europeField serviceCompany announcesExchange commission

Nevro Names Kevin Thornal as New Chief Executive Officer and President

Nevro Names Kevin Thornal as New Chief Executive Officer and President
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Redwood cityUnited statesKevin thornalD keith grossmanMichael demaneJulie deweyField serviceSkeletal healthExchange commissionCompany announcesSouthern methodist universityGlobal diagnostic solutionsHologic incCorp communicationsNevro corpKeith grossman

Nevro to Report First Quarter 2023 Financial Results

/PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of.

Redwood cityUnited statesJulie deweyCompany to host conference call onNevro corpCorp communicationsHost conference callSenza omniaInvestor relationsNevro corp

Nevro to Participate in Wells Fargo 2023 Medtech Innovation Spotlight Call Series

/PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of.

United statesRedwood cityJulie deweyD keith grossmanNevro corpPrnewswire nevro corpWells fargoCorp communicationsRod macleodChief financial officerDavid carawayChief medical officerInnovation spotlight call seriesSenza omniaInvestor relationsNevro corp

Nevro Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides First Quarter and Complete Full-Year 2023 Guidance

/PRNewswire/ Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of.

United statesRedwood cityJulie deweyD keith grossmanNevro corpPrnewswire nevro corpExchange commissionCorp communicationsBusiness highlightsConstant currency comparedFourth quarterDiabetic neuropathyIndication salesBringing first full yearProcedures increasedProcedures grew